ACTIVE

White Raven

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-592,4 k €+12,9 %over 1 year
Gross margin70,7 k €+124,4 %over 1 year
Equity2,5 M €+56,0 %over 1 year

Identity

Source · BCE/KBO

White Raven is a Public limited company incorporated in 2022. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Liège.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0782.537.107
Incorporation
23/02/2022
Legal form
Public limited company
Registered office
Boulevard de Patience et Beaujonc 3
4000 Liège · WallonieSee on map
Contributed capital
2 515 438,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 20700
Contacts
2 public details availableLog in to view
Signals
Healthy social debts

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin70,7 k €-289,4 k €-192,8 k €
EBITDA-200,5 k €-507 k €-212,5 k €
Operating result-250,1 k €-523,6 k €-213,6 k €
Net result-592,4 k €-680,4 k €-213,3 k €
Balance sheet
Equity2,5 M €1,6 M €2,3 M €
Total assets9,5 M €6,6 M €2,4 M €
Cash128,5 k €106,9 k €1,2 M €
Debts7 M €4,8 M €139,9 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 11 ended

Active mandates

Bernard WORONOFF

Director · until 25 mai 2029

Active
Ismael RIAZUL

Director · until 25 septembre 2029

Active
Johan LAMBERSENS

Director · until 25 mai 2029

Active
Liatris

Director · until 25 mai 2029 · 0781.619.664

Represented by VEREECKE Joachim

Active
Philippe VANDERHOFSTADT

Director

Active
RED RAVEN

Director · until 25 mai 2029 · 0722.852.116

Represented by WORONOFF Dimitri

Active

Ended mandates

BERNARD WORONOFF

Director · since 25 mai 2023 · until 25 mai 2029

Ended
Ismael RIAZUL

Director · since 25 mai 2023 · until 25 mai 2029

Ended
Johan LAMBERSENS

Director · since 25 mai 2023 · until 25 mai 2029

Ended
Liatris

Director · since 25 mai 2023 · until 25 mai 2029 · 0781.619.664

Represented by Joachim VEREECKE

Ended

Other companies at this address

Boulevard de Patience et Beaujonc 3 4000 Liège
CompanyCBE no.
Abscint● Active
0749.828.410
AMPACIMON● Active
0827.990.317
Amyl Therapeutics● Active
0758.775.372
BECARV● Bankrupt
0840.777.885
BE.SPINE● Active
1013.110.857
CEFALY Technology● Active
0870.578.661
DERMAX● Active
0667.730.677
DIANOSIC● Active
1034.558.646
DW Cefaly Holding● Active
0725.837.241
EARTH ALIVE CLEAN TECHNOLOGIES BELGIUM● Active
1023.778.481
EXO Biologics● Active
0732.982.379
ExoXpert● Active
1003.807.666
Hirundo Biosciences● Active
0681.855.065
HolyFox Invest● Active
1010.693.181
Hyloris● Active
0669.738.676
Hyloris Developments● Active
0542.737.368
Hyloris Pharmaceuticals● Active
0674.494.151
Hyloris Therapeutics● Active
1025.029.385
LEGIAPARK● Active
0728.589.170
MAN & SCIENCE● Active
0837.403.770

Full financial information

Source · NBB
202520242023
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202423/02/2022
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months23 months
Filing date19/08/202630/09/202522/07/2024
General meeting15/06/202617/06/202529/05/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202515/06/202619/08/2026FrenchPDF
Micro model31/12/202417/06/202530/09/2025FrenchPDF
Micro model31/12/202329/05/202422/07/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 11 ended

Active mandates

Bernard WORONOFF

Director · until 25 mai 2029

Active
Ismael RIAZUL

Director · until 25 septembre 2029

Active
Johan LAMBERSENS

Director · until 25 mai 2029

Active
Liatris

Director · until 25 mai 2029 · 0781.619.664

Represented by VEREECKE Joachim

Active
Philippe VANDERHOFSTADT

Director

Active
RED RAVEN

Director · until 25 mai 2029 · 0722.852.116

Represented by WORONOFF Dimitri

Active

Ended mandates

BERNARD WORONOFF

Director · since 25 mai 2023 · until 25 mai 2029

Ended
Ismael RIAZUL

Director · since 25 mai 2023 · until 25 mai 2029

Ended
Johan LAMBERSENS

Director · since 25 mai 2023 · until 25 mai 2029

Ended
Liatris

Director · since 25 mai 2023 · until 25 mai 2029 · 0781.619.664

Represented by Joachim VEREECKE

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office22/05/2024
    SIEGE SOCIAL
    PDF
  • Mandates07/06/2023
    MODIFICATION FORME JURIDIQUE - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Other25/02/2022
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-592,4 k €↑
  2. 2025
    Name changeWhite Raven
  3. 2024
    Annual accounts 2024-680,4 k €↓
  4. 2023
    Annual accounts 2023-213,3 k €
  5. 2023
    Name changeWHITERAVEN
  6. 23/02/2022
    IncorporationPublic limited company